HLL Biotech, a subsidiary of HLL Lifecare, has become the first public sector undertaking to launch cost-effective pentavalent vaccine (Pentahil) and Hepatitis B (Hivac-B) vaccine.
They will be made available initially in Kerala and Tamil Nadu, followed by other States. Lov Verma, Secretary, Ministry of Health and Family Welfare, launched them in New Delhi on Friday.
M Ayyappan, Chairman, HLL Biotech, was present.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.